GenEra Overview
- Year Founded
-
1998

- Status
-
Acquired/Merged
- Employees
-
12

- Latest Deal Type
-
M&A
- Financing Rounds
-
1
GenEra General Information
Description
Operator of a biotechnology company specializing in the fields of gene transfer and gene therapy. The company develops a variety of genetically modified tissues as a means of treating a range of diseases that are caused by defects in circulating proteins and other molecules, such as high cholesterol levels.
Contact Information
Website
www.generaspa.it
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Office
- Istituto Scientifico H. San Raffaele
- Via Olgettina, 58
- 20132 Milan
- Italy
GenEra Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
GenEra Patents
GenEra Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-2375349-A1 | A method for the transfer of antigens to dendritic cells | Inactive | 28-May-1999 | 0000000000000 | |
AU-5215900-A | A method for the transfer of antigens to dendritic cells | Active | 28-May-1999 | 0000000000000 | |
AU-772703-B2 | A method for the transfer of antigens to dendritic cells | Inactive | 28-May-1999 | 0000000000000 | 0 |
EP-1185626-A2 | A method for the transfer of antigens to dendritic cells | Inactive | 28-May-1999 | 0000000000000 | |
EP-1179019-A2 | Immunogenic peptides derived from mage and the use thereof | Inactive | 21-May-1999 | C07K14/4748 |